BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3508397)

  • 1. [Seroconversion of HBeAg into anti-HBe in chronic hepatitis type B].
    Stránský J; Vodák M; Zichová M; Votruba T; Choluj B
    Cas Lek Cesk; 1986 Oct; 125(44):1353-6. PubMed ID: 3508397
    [No Abstract]   [Full Text] [Related]  

  • 2. [Spontaneous seroconversion of HBeAg into anti-HBe in patients with chronic hepatitis B].
    Hadzić N; Vucelić B; Dubravcić D; Juricić M; Stavljenić A
    Lijec Vjesn; 1988; 110(6-7):181-4. PubMed ID: 3185086
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prognostic significance of the HBeAg-anti-HBe system in acute hepatitis B].
    Ketiladze ES; Vorozhbieva TE; Matveev VA; Bugaeva NP
    Ter Arkh; 1986; 58(10):23-6. PubMed ID: 3798343
    [No Abstract]   [Full Text] [Related]  

  • 4. [HBeAg/anti-HBe system in acute viral hepatitis B].
    Gvojić B; Miling M
    Lijec Vjesn; 1985 May; 107(5):191-5. PubMed ID: 4010449
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and pathophysiological aspects of chronic active hepatitis.
    Iwamura K
    Tokai J Exp Clin Med; 1986; 11 Suppl():147-57. PubMed ID: 3452239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of HBeAg and HBsAg seroconversion in patients with chronic hepatitis B.
    Stránský J; Chlumská A; Zichová M; Helm R; Mankovecký L; König J
    Sb Lek; 1993; 94(4):317-25. PubMed ID: 7992018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
    Chlumská A; Stránský J; Taimr P; Baumruk L; Nevaril M
    Vnitr Lek; 1995 Jul; 41(7):445-8. PubMed ID: 7571477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
    Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
    Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
    [No Abstract]   [Full Text] [Related]  

  • 10. [A clinicopathological study of seroconversion from HBeAg to anti-HBe in patients with chronic hepatitis B].
    Liu JH; Yan JC; Wang HP
    Zhonghua Nei Ke Za Zhi; 1988 Oct; 27(10):621-3, 653. PubMed ID: 3229186
    [No Abstract]   [Full Text] [Related]  

  • 11. Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.
    Loriot MA; Marcellin P; Talbodec N; Guigonis V; Gigou M; Boyer N; Bezeaud A; Erlinger S; Benhamou JP
    Hepatology; 1995 Mar; 21(3):627-31. PubMed ID: 7875659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
    Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
    Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS; Sung JL; Lai MY
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Co-existence of HBeAg and anti-HBe in a subject with prolonged hepatitis B].
    Cirelli A; Catania S
    Clin Ter; 1981 Jul; 98(2):215-7. PubMed ID: 7261568
    [No Abstract]   [Full Text] [Related]  

  • 15. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
    Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
    Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: no association between genome conversion and seroconversion.
    Maruyama T; Kuwata S; Koike K; Iino S; Yasuda K; Yotsuyanagi H; Moriya K; Maekawa H; Yamada H; Shibata Y; Milich DR
    Hepatology; 1998 Jan; 27(1):245-53. PubMed ID: 9425944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The behavior of the HBeAg-anti-HBe system in chronic hepatitis].
    Musca A; Cordova C; Barnaba V; Bonavita MS; Zaccari C; Levrero M
    Minerva Dietol Gastroenterol; 1983; 29(1):19-26. PubMed ID: 6843853
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HBeAg and anti-HBe antibodies in chronic liver diseases].
    Bereszyńska I; Juszczyk J; Kryska A; Kaczmarek Z; Krajewski P
    Pol Tyg Lek; 1987 Apr; 42(14):409-12. PubMed ID: 3615268
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
    Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.